NASH 동물모델에서 인진청간탕과 인진사령산의 효과규명
Effect of Injinchunggan-tang & Injinsaryung-san on NASH induced by MCD-diet in A/J mice
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Objective : The aim of this study is to investigate the preventive effect of Injinchunggan-tang (YJCGT) & Injinysaryung-san (YJSRS) on MCD-diet-induced NASH in A/J mice. Methods : A/J mice were divided into 4 groups; Normal group (normal diet without any treatment), Control group (MCD diet only), YJCGT group (MCD diet with YJCGT), and YJSRS group (MCD diet with YJSRS). After 5 weeks, body weight, liver weight, biochemical parameters for liver function test, histological changes, and real-time PCR were assessed. Results : Mice lost body weight with the MCD diet and the YJCGT and YJSRS groups lost less than the control group, though showed no statistical significance. Liver weights were decreased by the MCD diet, but not significantly. In the liver function test, all the values were increased with the MCD diet, though some did not show significance. Alp and ALT levels were significantly less increased by YJCGT compared to the normal (p<0.05). All values were decreased or increased compared to the control by treatment though showed no significance possibly due to insufficient sample numbers. In histological findings of the livers, MCD-diet induced severe fatty change and collagen accumulation in the livers, but this fatty change was reduced in the YJCGT and YJYRS groups and fibrogenesis was inhibited significantly with p<0.05 and p<0.01, respectively. In real-time PCR analysis, YJCGT and YJYRS showed inhibitory effect on liver fibrogenesis by reducing associated gene expressions caused by MCD diet. Conclusion : YJCGT and YJSRS are considered to be possible candidates for the treatment of patients with NASH and/or liver fibrosis.
Abstract
Objective : The aim of this study is to investigate the preventive effect of Injinchunggan-tang (YJCGT) & Injinysaryung-san (YJSRS) on MCD-diet-induced NASH in A/J mice. Methods : A/J mice were divided into 4 groups; Normal group (normal diet without any treatment), Control group (MCD diet only), YJCGT group (MCD diet with YJCGT), and YJSRS group (MCD diet with YJSRS). After 5 weeks, body weight, liver weight, biochemical parameters for liver function test, histological changes, and real-time PCR were assessed. Results : Mice lost body weight with the MCD diet and the YJCGT and YJSRS groups lost less than the control group, though showed no statistical significance. Liver weights were decreased by the MCD diet, but not significantly. In the liver function test, all the values were increased with the MCD diet, though some did not show significance. Alp and ALT levels were significantly less increased by YJCGT compared to the normal (p<0.05). All values were decreased or increased compared to the control by treatment though showed no significance possibly due to insufficient sample numbers. In histological findings of the livers, MCD-diet induced severe fatty change and collagen accumulation in the livers, but this fatty change was reduced in the YJCGT and YJYRS groups and fibrogenesis was inhibited significantly with p<0.05 and p<0.01, respectively. In real-time PCR analysis, YJCGT and YJYRS showed inhibitory effect on liver fibrogenesis by reducing associated gene expressions caused by MCD diet. Conclusion : YJCGT and YJSRS are considered to be possible candidates for the treatment of patients with NASH and/or liver fibrosis.
참고문헌 (28)
- 이동석, "비알코올성 지방간염의 진단 및 간섬유화 정도의 예측인자", 대한내과학회지, 67(3), pp.231~240 (2004), 대한내과학회
- 진소영, "지방간", 대한간학회지, 12(1), pp.112~115 (2006)
- 연종은, "비알코올성 지방간 질환의 임상적 의의", 가정의학회지, 24(6), pp.2~515 (2003), 대한가정의학회
- Rinella ME, "The methionine-choline deficient dietary model of steatohepatitis dose not exhibit insulin resistance", J Hepatol, 40, pp.47~51 (2004)
- Begriche K, "Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it", Mitochondrion, 6, pp.1~28 (2006)
- 우홍정, "만성B형간염에 대한 인진청간탕의 효과", 제2회한중학술대회참가논문집, pp.18~53 (1995)
- 이지현, "인진분획물이 인체간세포의 TGF-β1 induced apoptosis에 미치는 영향", 대한한의학회지, 20, pp.53~61 (2000)
- 강우성, "茵蔯淸肝湯이 HepG2 cell의 TNF-a 신호전달계에 미치는 影響", 대한한방내과학회지, 25(1), pp.28~45 (2004), 대한한방내과학회
- 표임정, "인진사령산이 간세포활성, 세포주기 및 Fas-mediated apoptosis에 미치는 영향", 경희한의대논문집, 22, pp.119~140 (1999)
- 고흥, "인진사령산 분획물이 간세포활성, 세포주기 및 Fas-Mediated Apoptosis에 미치는 영향", 대한한의학회지, 21, pp.174~185 (2000)
- 지형준, "대한약전외 한약(생약) 규격집 주해서" (1988), 한국메디칼인덱스사
- 박중원, "지방간의 진단과 치료", 대한내과학회지, 7, pp.64~70 (2001), 대한내과학회
- 강지현, "성인 남성에서 비알코올성 지방간 질환과 대사증후군과의 관련성", 가정의학회지, 25(10), pp.746~753 (2004), 대한가정의학회
- 김상진, "비알코올성 지방간 환자에서 지방간염의 심화도를 예측할 수 있는 임상적 지표들", 대한간학회지, 6(1s), pp.16~ (2000)
- Ludwig J, "Nonalcohlic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed diease", Mayo Clinic Proc, 55, pp.434~438 (1980)
- 박도윤, "비알코올성 지방간질환과 알코올성 간질환의 병리학적 감별진단", 대한간학회, 9(1s), pp.71~77 (2003)
- 오희주, "초음파로 진단된 지방간에서 알코올성 지방간과 비알코올성 지방간의 임상양상", 대한소화기학회 추계학술대회지, 41, pp.632~ (2003)
- Andrew J, "Genes of the Antioxidant Response Undergo Upregulation in a Rodent Model of Nonalcoholic Steatohepatitis", J BIOCHEM MOLECULAR TOXICOLOGY, 219, pp.216~220 (2007)
- Haruko Sugino, "Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis", J Gastroenterol Hepatol (2008)
- Chawla RK, "S-adenosylmethionine deficiency and TNF-alpha in lipopolysaccharide -induced hepatic injury", Am J Physiol, 275, pp.G125~G129 (1998)
- 김진주, "인진청간탕이 MHV-2로 유발된 마우스의 손상간에 미치는 영향", pp.1996
- 강경태, "인진청간탕가미방이 실험적 흰쥐의 간경변증에 미치는 영향", 경희한의대논문집, 20, pp.133~150 (1997)
- 홍상훈, "인진청간탕가미방이 간세포활성세포주기 및 apoptosis에 미치는 영향", 대한한의학회지, 19, pp.337~372 (1998)
- Nieto N, "CYPEI mediated oxidative stress induced collagen type1 expression in rat hepatic stellate cells", Hepatology, 30, pp.987~996 (1990)
- Olaso E, "Molecular regulation of hepatic fibrogenesis", J Hepatol, 29, pp.836~847 (1998)
- Gres sner AM, "Cytokines and cellular cros stalk involved in the activation of fat storing cells", J Hepatol, 22, pp.28~36 (1995)
- 박근칠, "Transforming Growth factorβ와 악성종양", Korean Society of Medical Biochemistry and Molecular Biology News, 3, pp.21~24 (1996)
- Ip E, "Administration of the potent PPARα agonist, Wy-14, 643, reverses nutritional fibrosis and steatohepatitis in mice", Hepatology, 39, pp.1286~1296 (2004)